Innovative AI-driven workflow enables the 3D printing of patient-specific finger joint implants
The 3D Printing Industry Awards 2022 shortlists are now available for voting. Who will win the 2022 3DPI Awards? Have your say by casting your vote now.
News and Insights of 3D Printing and Manufacturing
HomeMedical
The 3D Printing Industry Awards 2022 shortlists are now available for voting. Who will win the 2022 3DPI Awards? Have your say by casting your vote now.
Clear aligners continue to increase in demand and 3D printing has proven to be an ideal technology to produce these mass-customized devices. Silicon Valley-based Carbon has made clear aligners one of its top priorities for expansion in the European market by offering the most seamless solution to produce them at scale using its L1 production solution optimized for clear aligner models. As a Sales Director for dental aligner solutions in Europe, Lea McGurk, has been tasked with helping dental laboratories across Europe understand the benefits of turning to Carbon’s turnkey, the subscription-based business model for their clear aligner production requirements. In this exclusive interview, we dig a little deeper into how Carbon makes it possible to go from one printer to a fleet of printers.
Med-tech startup Axial3D has announced the closing of a $15 million investment round led by a strategic investment of $10 million from Stratasys Ltd. (NASDAQ: SSYS), a leader in polymer 3D printing solutions. This is Stratasys’ first investment in Axial3D. The two companies also will be providing a joint offering to make patient-specific 3D printing solutions for hospitals and medical device manufacturers more accessible so it becomes a mainstream healthcare solution.
Carbon’s developmental bioabsorbable elastomer platform has demonstrated biocompatibility in vivo, with all samples being designated as non-toxic and exhibiting tunable times for full absorption. This latest milestone indicates the elastomer’s potential future development in biomedical lattice applications such as soft tissue repair, wound dressings, and nerve conduits.
Lincotek, a leader in the production of metal medical devices via additive manufacturing, reported it has produced over 800,000 medical devices since the company started working with Additive Manufacturing in 2006. In recent years, the count has topped over 100,000 3D printed parts per year, with best-in-class yield rates, material consumption and per-unit costs.
Scientists from the Ural Federal University (UrFU) and the Ural Branch of the Russian Academy of Sciences are determining the optimal conditions for 3D printing permanent magnets from hard magnetic compounds based on rare-earth metals. This will make it possible to start small-scale production of magnets, in any shape, and create complex magnet configurations. Such magnets are suitable for miniature electric motors and electric generators, on which pacemakers work. In addition to this, as is typical of AM, the technology minimizes production waste and has a shorter production cycle. A description of the method and experimental results are presented in the Journal of Magnetism and Magnetic Materials.
SprintRay Inc., an industry leader in digital dentistry and 3D printing solutions, has launched OnX Tough, a next-generation hybrid ceramic resin designed for 3D printing dental applications. Leveraging SprintRay’s proprietary NanoFusion technology, this new resin delivers durability and lifelike translucency for high-quality, same-day dental prosthetics.
Over the past few decades, there has been a growing focus in the healthcare industry on achieving better patient outcomes. This emphasis is increasing the popularity of personalized medical devices, which are designed to match the anatomy or physiology of each patient.
By adding process enhancements to its AM contract manufacturing workflow, Amnovis has expanded its potential for patient-specific and standard medical device innovation.
3D LifePrints, a UK-based medical 3D printing specialist, has received clearance from the United States Food and Drug Administration (FDA), for their EmbedMed personalized surgery platform.